{
    "title": "Individual feed for http://feeds.benzinga.com/benzinga",
    "link": "http://feeds.benzinga.com/benzinga",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-11-24T11:08:01.881188",
    "items": [
        {
            "title": "VinFast Auto Poised For Almost 100% Growth In Deliveries In 2025",
            "link": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/11/49033635/vinfast-auto-poised-for-almost-100-growth-in-deliveries-in-2025",
            "description": "Around 95% of VinFast Auto's total deliveries are domestic; the company is likely to hit total deliveries of 185,000 this year. read more",
            "pubDate": "2025-11-24T15:58:03",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/11/24/VinFast-EV-maker--Vietnam.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "Alibaba Q2 Preview: Qwen's 10 Million Milestone Highlights 'Historic Opportunities' In AI, Cloud",
            "link": "https://www.benzinga.com/trading-ideas/previews/25/11/49033535/alibaba-q2-preview-qwens-10-million-milestone-highlights-historic-opportunities-in-ai-clou",
            "description": "Cloud and AI are the two growth segments for Alibaba Group and will be closely watched in Q3 financial results Tuesday. read more",
            "pubDate": "2025-11-24T15:54:50",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/11/24/Alibaba_1.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "Is A Fed Cut A Strong Enough Catalyst?",
            "link": "https://www.benzinga.com/Opinion/25/11/49033470/is-a-fed-cut-a-strong-enough-catalyst",
            "description": "Markets rally on a revived rate-cut narrative, crypto hints of a near-term bottom, and a potential China export unlock for Nvidia. Fed Cut Odds Surge ...",
            "pubDate": "2025-11-24T15:51:59",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/11/24/Gav-Blaxberg.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "Capricor Therapeutics (CAPR) Stock Is Sliding Today: Should Retail Investors Be Worried?",
            "link": "https://www.benzinga.com/trading-ideas/movers/25/11/49033248/capricor-therapeutics-capr-stock-is-sliding-today-should-retail-investors-be-worried",
            "description": "Capricor Therapeutics shares are trading lower Monday morning after the company reported data from its exosome-based drug delivery platform. read more",
            "pubDate": "2025-11-24T15:47:56",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/11/24/Gloves--Test-And-Doctor-With-Medicine--S.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "$1000 Invested In Phillips 66 5 Years Ago Would Be Worth This Much Today",
            "link": "https://www.benzinga.com/insights/news/25/11/49033177/1000-invested-in-phillips-66-5-years-ago-would-be-worth-this-much-today",
            "description": "read more",
            "pubDate": "2025-11-24T15:45:38",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png"
        }
    ]
}